2012– 25th September, Royal College of Physicians, London (including non-clinical & clinical tracks)

Registration & Contact Details Booking Rates

Package Price Features Biotech & Pharma Delegate Rate £215 + VAT per delegate Single delegate pass(Available to non-service organisation only) Biotech Outsourcing Strategies 2012 CRO Delegate Pass £1550 + VAT per delegate Single delegate Featured Speakers BOS 2012 Discovery, early development & clinical operations outsourcing CRO Silver Package £1800 + VAT Single delegate plus Branding CRO Silver Package £2050 + VAT 2 Delegates plus Branding Dr James Willson, Gareth Lewis Pia Sauer Larsen Dr.Maribel Crespo Dr Tamzin Blagbrough Banner Stand Exhibition Sponsor £2500 + VAT 2 Delegates + Stand + Branding Senior Clinical Scientist, Shire Functional Sourcing Manager, Pfizer R&D Outsourcing Manager, Clinical Head of Discovery Alliances, Drug European Outsourcing Coordinator, joining the senior leadership team Pharmaceuticals (Clinical Track) (Clinical Track) Outsourcing Management, LEO Discovery Division, Almirall Exhibition Package £2750 + VAT 2 Delegates + Stand + Branding Lilly UK in the Respiratory business Unit Pharma A/S to manage their early portfolio Exhibition Package £3000 + VAT 3 Delegates + Stand + Branding James Willson joined Shire Gareth is currently a Functional Dr.Maribel Crespo has been Tamzin has worked for Lilly for 20 in 2005. In 2009 he assumed Pharmaceuticals in September Sourcing Manager based at Pfizer Pia Sauer Larsen has15 years’ with for Almirall for 20 years Gold Package £4500 + VAT 3 Delegates + Speaker Slot + Stand years in a variety of roles, starting responsibility for Outsourcing 2011 as a Senior Clinical Scientist. UK, located in Walton Oaks, near experience in various roles related covering most aspects of the + Branding in the analytical labs, progressing and Business Development for Dorking in Surrey. Gareth has been to Clinical Development. She Drug Discovery process. With a to be a project manager and most Molecular Discovery at GSK, a He holds a PhD in Neuro- involved in Clinical Research for is currently working in the R&D degree and PhD in Chemistry, she Key Sponsor £7500 + VAT See media pack for details recently as part of the outsourcing department providing early phase pharamacology obtained at the over 20 years, working across a Outsourcing Function at LEO started her career as Medicinal group. In this role she is scientific support to targets in Additional Delegate Pricing for University of Southampton in broad range of drug development Pharma A/S, a leading global chemist, being appointed later responsible for placing all phase I the preclinical phase of Drug CROs (only in addition to one of 2003. After a brief postdoctoral programmes covering pharma company specialising in as Discovery project leader and work outside of the US. In addition Discovery. Mike left GSK in 2010 the package outlined above) £390 + VAT position again at Southampton phases I-IV. Most of Gareth’s dermatology and critical care. Therapeutic Area head. More she is the relationship manager for to join Innovative Medicines University he left to begin a career experience has been gained recently she has joined the Sole Trader Consultant Rate the phase I strategic relationship at AstraZeneca as Head of in clinical research. within the commercial arena Previously Pia was working Discovery Alliances group. In (applicable to Sole Trader or with Covance. She has a degree Discovery Research. With groups of pharmaceutical companies, as Strategic Procurement this role, she is responsible of Limited Company where and a PhD in Chemistry. in Sweden, the UK and the US, his proprietor consultant is the In 2004 James joined the Clinical designing and implementing management function at Genmab Discovery Outsourcing activities current group focuses on internal sole employee) £390 + VAT Research Organisation ICON trials which have supported the A/S, and in a DM role at Nycomed and Medicinal Chemistry and Hit and collaborative research to Clinical Research as a Clinical development of some of the Denmark Aps mainly focusing on Finding Partnerships. provide a comprehensive range Research Associate. In 2010, James most well-known & commercially the relationship and outsourced The Biotech & Pharma Booking Rate is set at £215 + VAT – this rate is only available to non contract service of technical and translational became a project manager at successful prescription medicines. DM services between DM CROs Dr Mike Snowden activities to preclinical project provider attendees VP & Head Discovery Sciences, ICON. While at ICON he worked As Director of the UK Clinical and the clinical teams and also teams including, HTS and SAR AstraZeneca Insight from expert speakers including; Group Booking Discount: BOS 2012 will be appropriate for non-clinical & clinical R&D professionals in your on a number of global trials (with Research Group at Pfizer, Gareth spent more than 8 years in a Data screening, X-ray crystal/biophysics organisation. Bio2Business is happy to offer generous discounts to enable your team to attend. sites in EU, Americas, Asia Pacific) has led that organisation through Management Unit at a centralized support, statistics, and bio-reagent Mike joined Glaxo Group Research Mike Snowden Gareth Lewis Call us on +44 (0)207 691 3568 or email: [email protected] for further details. in various indications. several significant organisational imaging CRO and in the Danish generation and assay development in the UK in 1988 after completing changes, including the integration Cancer Society. capabilities. VP and Head Discovery Sciences, AstraZeneca Functional Sourcing Manager, Pfizer Ways to Register: Currently at Shire Pharmaceuticals with Wyeth. In his current a PhD and postdoctoral studies he is a study manager working role, Gareth has supported the at Liverpool University. Recruited Online: www.bio2business.com or www.bio2business.com/registrations.php Colin Green James Willson on a large global programme of implementation of an outsourced as a microbial biochemist and Telephone: +44 (0)207 691 3568 clinical trials. clinical operations partnership enzymologist, he worked initially Principal Research Scientist, Tox/ADME, Chorus Senior Clinical Scientist, Shire Pharmaveuticals with Quintiles, involving the on anti-infectives and then in the Europe Email: [email protected] or [email protected] delivery of clinical trials across 30 Cardiovascular and Respiratory Tamzin Blagbrough areas where he led a number Post: Bio2Business Ltd. London BioScience Innovation Centre, 2 Royal College Street, London, NW1 0NH countries globally. Over the past 2 Simon Cruwys European Outsourcing Co-ordinator, Lilly UK years, Gareth has led the complex of early phase dyslipidemia and Head of Inflammation Pharmacology, Grunenthal transition of ongoing clinical trials inflammation projects. In 2001 at Enquiry Form (if you prefer to register your interest by post please complete the form below) between CRO partners, in order to the formation of GSK, Mike was achieve strategic organisational appointed to head a cross therapy A must attend one day event that: Name Job Title goals. area group providing HTS and SAR screening support to the CNSP Analyses best practice in R&D outsourcing for virtual biotech and pharma and Respiratory groups in the UK, Email Telephone Delivers a platform for virtual biotech and pharma to strengthen Company Enquiry Type outsourcing relationships and forge new partnerships Creates the ideal environment to build networks in R&D and outsourcing I would like to register Please contact me for to discuss further Promotional code Ref: visit www.bio2business.com to view all our speaker biographies

Please send your completed form to Bio2Business Ltd, London BioScience Innovation Centre, 2 Royal College Street, London, NW1 0NH www.bio2business.com Sponsoring “Biotech Outsourcing Strategies 2012” presents a highly effective opportunity for contract Drinks Reception in the College Gardens – At the end of the service providers to position expertise and capabilities to industry decision makers. Sponsorship day’s proceedings all delegates, speakers and sponsors are opportunities include speaker participation, stand space, events media branding and more. invited to an evening drinks reception in the gardens of the Royal College of Physicians Contact Bio2Business Ltd on +44 (0)207 691 3568 or email: [email protected] Exhibition Presentation Partnering Networking or [email protected] to discuss further Key CRO Sponsors Introduction to BOS 2012 and to the BOS Events Formula Non-clinical track Clinical Track

08.00 Registration breakfast and 12.00 High priority on high potents 08.00 Registration breakfast and partnering 11.40 Translational Pharmaceutics: Launched in 2006 BOS Events are niche, Very useful, a good mix of partnering Dr Michael Quirmbach, Sr. Innovation in the early development outsourcing focused partnering events for lecture topics and time to Manager Business Development 09.30 Strategic Clinical Outsourcing process Gold Sponsors meet new contacts 09.30 Discovery Module and Technology Manager HPAIs, Dr Module Mr Kieron Hall, Vice President the biotech, pharma and contract services Chair: Prof Hugh Marston, Head Chair:Dr Keith Borkett, Director of Dr Paul Briner, Reddy’s Business Development, Quotient community. The 1 day event formula includes of Pharmacology, TPP Global Clinical Operations, Paion UK Ltd Bioresearch Director Chemical Development, Development 12.10 William Harvey Research Limited high quality presentations from thought Prosidion Ltd - A preclinical CRO in an academic 09.30 Managing change when evolving to a 11.50 Harnessing the value of adaptive leaders in the industry, 1 to 1 partnering, 09.30 Harnessing advances in translational environment strategic partner outsourcing model clinical trials exhibition and informal networking. research to approach attrition at Professor Chris Thiemermann, Mr Gareth Lewis, Functional Sourcing Dr Laurent Spiess, Vice President, discovery and how external R&D can Chairman and Chief Executive, Manager, Pfizer UK Business Development, Adaptive Very beneficial. I could meet effectively partner with Pharma William Harvey Research Ltd Clinical Trials, Aptiv Solutions with many existing partners Dr Mike Snowden, VP and Head of 10.00 Functional vs. full outsourcing: evaluating in a short space of time and Discovery Sciences, AstraZeneca 12.20 Saving cost through the application the best approach for your company 12.30 Lunch and partnering BOS 2012 will feature non-clinical and Dr Pia Sauer Larsen, R&D Outsourcing discover lots of new ones of High Performance Capillary clinical tracks creating more opportunities 10.00 Building a pharmacological platform Manager, Clinical Outsourcing 14.00 Clinical Operations Outsourcing - some of which I hadn’t Electrophoresis for analytical Exhibition Sponsors for interaction between clinical and non- of evidence to support out-licensing outsourcing Management, LEO Pharma A/S Module known existed before the Dr Simon Cruwys, Head of Chair: Dr Stephen Greentree, clinical teams. As an attendee at BOS 2012 Dr Stuart Hassard, Chief Scientific meeting. Inflammation Pharmacology, Officer, deltaDOT 10.30 Outsourcing partnership models Director Global Portfolio you can expect to develop your skills and Dr Chris Hobbs, Grunenthal at Phase I: case studies in phase I Management, Mylan build your outsourcing relationships all Group Director of Chemistry, 12.30 Lunch and partnering contracting 10.30 Managing discovery chemistry Dr Tamzin Blagbrough, European 14.00 Understanding regulatory hurdles In in a relaxed atmosphere. Here are some Proximagen Neuroscience partnerships 14.00 Early Development Outsourcing Coordinator, Lilly UK early clinical Development comments from past attendees..... Dr Maribel Isabel Crespo, Head of & Outsourcing Case Study Tacye Connolly, Director & Owner, Discovery Alliances, Almirall 11.00 Coffee break and partnering Bio2Business have an Module Regulatory Resources Group extraordinary track record Chair: Dr Sarah Nesfield,Director, 11.00 Coffee break and partnering CRO Management, Scinovo, 11.30 Technology Showcase 14.30 Is clinical procurement putting the in bringing together key GlaxoSmithKline Chair: Anthony Walker, Partner, cart before the horse? people in non-clinical 11.30 Technology Showcase Alacrita Consulting Mr Roger Joby, Managing Director, pharmaceutical research. Chair: Alan Harris, Owner, Alacrity 14.00 Communication in outsourcing: 1to1to1. Their events are vital to our Pharma Associates avoiding common pitfalls, managing 11.30 Early phase clinical trials: key success Silver Sponsors commercial activities cultural divides, maximising vendor factors 15.00 Challenges of monitoring Patrick Falvey, 11.30 Services beyond drug substance attention Dr Peter MacLennan, Director of international trials sites manufacture Project Development and Scientific Sales Executive, Celtic Catalysts Dr Colin Green, Toxicology Project Dr James Willson, Senior Clinical Sonal Naik, Sales Representative, Leader, Lilly UK Affairs, ORION Clinical Services Ltd. Scientist, Shire Pharmaceuticals CARBOGEN AMCIS 14.30 Anatomy of a typical API project 15.30 Coffee break and partnering 11.40 Some considerations in the Dr Paul Madeley, Managing 16:00 development of synthetic peptides Director, Synth-Isis Ltd Plenary Module - Outsourcing Strategy destined for first-in-human activity Strategy Dr Gareth Maguire, Business 15.00 Sourcing case study Chair: Sharon Grimster, VP Development, F Star Development Manager, Almac - vendor perspective 16:00 Drug discovery outsourcing Developing an integrated outsourcing strategy - Who should attend BOS Events? the Bayer approach From Biotech & Pharma: Executives involved with the following disciplines: discovery biology, discovery 11.50 Key expertises in process John Ellingboe, Senior VP of Dr Jens Gysler, External Cooperations, Bayer chemistry, pharmacology, DMPK, lead validation, lead optimisation, in vitro ADME, early scale up, scale development and API manufacturing Discovery Chemistry, GVK Banner Sponsors Dr Jean-Paul Hermet, Business Pharma AG up, pre-formulation, formulation, CMC, regulatory affairs, clinical development, clinical operations, Biosciences Pvt Ltd Development Manager, Bachem project managers, programme managers, clinical research, outsourcing managers, contracts managers 16.50 Q&A session from CROs and CMO – business development, sales, marketing and corporate management functions 15.30 Coffee break and partnering 17.00 Drinks Reception

Correct at date of print 14th September 2012